Cite
HARVARD Citation
Yabe, D. et al. (2021). IGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial. Journal of diabetes investigation. 12 (11), pp. 1992-2001. [Online].